HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Completed · Not applicable

Conditions studied: Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Human Papilloma Virus Infection Type 6, Cervical Cancer, Genital Warts, Oropharyngeal Cancer

In brief

Randomized, 2-arm observational study. The 2 arms (randomized at the level of health care provider) will be: 1. usual practice; 2. automated reminders to recommend 2nd and 3rd doses of HPV vaccine for eligible male and female adolescents who have initiated vaccination.

Key facts

Study ID

NCT02558803

Run by

Regenstrief Institute, Inc.

People needed

1305

Starts

2015-02-01

Expected to finish

2016-05-01

Last updated by the study team

2016-05-25

Who can join

Age: 11 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provider Criteria
• All pediatricians and nurse practitioners who provide health care at the 5 CHICA clinics will be included in this study
• Subject Criteria
• Patients will be 11-17 year old
• Males and females
• A visit to at least one of the five CHICA clinics
• Eligible for the 2nd or 3rd dose of HPV vaccine

You may not qualify if…

• Patients in the eligible age range who have not started or have completed the HPV vaccine series will be excluded

Where it is running

• Eskenazi Health Outpatient Care Center — Indianapolis, Indiana, United States
• Eskenazi Health Center Blackburn — Indianapolis, Indiana, United States
• Eskenazi Health Center Forest Manor — Indianapolis, Indiana, United States
• Eskenazi Health West 38th Street — Indianapolis, Indiana, United States
• Eskenazi Health Center Pecar — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.